Vestcor Inc’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Hold
71,721
– – 0.03% 477
2026
Q1
$891K Buy
71,721
+61,189
+581% +$822K 0.02% 536
2025
Q4
$133K Sell
10,532
-12,874
-55% -$147K ﹤0.01% 1023
2025
Q3
$234K Buy
23,406
+16,365
+232% +$147K 0.01% 946
2025
Q2
$57K Buy
+7,041
New +$53.1K ﹤0.01% 1098
2025
Q1
– Sell
-31,393
Closed -$249K – 1163
2024
Q4
$249K Hold
31,393
– – 0.01% 926
2024
Q3
$261K Hold
31,393
– – 0.01% 901
2024
Q2
$199K Hold
31,393
– – 0.01% 945
2024
Q1
$190K Buy
31,393
+14,815
+89% +$83.5K 0.01% 981
2023
Q4
$101K Buy
+16,578
New +$73.8K ﹤0.01% 1087

Other funds holding AMRX

Vestcor Inc's AMRX Position: Q2 2026 in Review

Vestcor Inc held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 71,721 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #477.

Vestcor Inc first reported a position in AMRX in Q4 2023 and has held it in 10 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Vestcor Inc held 71,721 shares of Amneal Pharmaceuticals worth $1.24M as of Q2 2026.
  • Vestcor Inc left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up 0.03% of Vestcor Inc's portfolio in Q2 2026, its #477 holding.
  • Vestcor Inc first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.